As monkeypox cases increased in the US and abroad, a report from the CDC’s Advisory Committee on Immunization Practices (ACIP) outlined data supporting the November 2021 decision to recommend JYNNEOS, a newer vaccine against monkeypox and smallpox, for individuals at risk of occupational exposure.
